VRDN
VRDN
NASDAQ · Biotechnology

Viridian Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$17.32
+0.04 (+0.23%)
As of Jun 24, 8:50 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 21 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +268.6% upside
Low Target $43.31
Average Target $63.84
High Target $68.31
Current Price $17.32
Current
$17.32
Target
$63.84
$43.31 $63.84 avg $68.31
Scenario Analysis
Bear Case
$43.31
150.1%
Low target
Base Case
$63.84
+268.6%
Avg target
Bull Case
$68.31
+294.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$34.29
-49.5% from high
52-Week Low
$13.18
+31.4% from low
50-Day SMA
$31.51
-45.0% vs SMA
200-Day SMA
$22.43
-22.8% vs SMA
RSI (14)
17.6
Oversold
Target vs 52W High
$63.84
+86.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%